Donkor Peter
Maxillofacial Surgery Unit, Department of Surgery, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
J Oral Maxillofac Surg. 2007 Jul;65(7):1292-6. doi: 10.1016/j.joms.2006.10.049.
This report aims to describe a technique used by the author for the management of head and neck keloid.
This is a clinical review of patients presenting with new and recurrent keloid of the head and neck to the Maxillofacial Surgery Unit at the Komfo Anokye Teaching Hospital, Kumasi, Ghana. The surgical technique involved the intralesional excision of the bulk of the keloid. Primary closure of the ensuring defect was achieved at operation. At the time of suture removal between 10 and 14 days postoperative, 40 mg triamcinolone was injected into the residual lesion. The injection was repeated on 2 more occasions at monthly intervals. All patients were followed up for at least 2 years.
Eighteen patients were successfully treated with no sign of recurrence in any of them. The main complication was hypo-pigmentation at the site of the original lesion.
The technique was found to be effective for the treatment of moderately sized new and recurrent keloid scars of the head and neck and is therefore recommended.
本报告旨在描述作者用于治疗头颈部瘢痕疙瘩的一种技术。
这是对加纳库马西Komfo Anokye教学医院颌面外科收治的头颈部新发及复发性瘢痕疙瘩患者的临床回顾。手术技术包括对大部分瘢痕疙瘩进行病损内切除。术中对形成的缺损进行一期缝合。术后10至14天拆线时,向残留病损内注射40毫克曲安奈德。每隔1个月再重复注射2次。所有患者均随访至少2年。
18例患者均成功治愈,无一例复发迹象。主要并发症是原病损部位色素减退。
该技术被发现对头颈部中度大小的新发及复发性瘢痕疙瘩瘢痕的治疗有效,因此推荐使用。